D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 71 Citations 18,501 292 World Ranking 14822 National Ranking 620

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Gene

His primary areas of investigation include Surgery, Bone marrow, Transplantation, Internal medicine and Mesenchymal stem cell. The concepts of his Bone marrow study are interwoven with issues in Cellular differentiation, Progenitor cell, Stem cell, Molecular biology and Cohort. The Internal medicine study combines topics in areas such as Gastroenterology and Oncology.

Armand Keating interconnects Clinical uses of mesenchymal stem cells, Stromal cell, Cancer research, Immunology and Neuroscience in the investigation of issues within Mesenchymal stem cell. As a part of the same scientific family, Armand Keating mostly works in the field of Immunology, focusing on Haematopoiesis and, on occasion, Imatinib mesylate. His studies examine the connections between Neuroscience and genetics, as well as such issues in Cell therapy, with regards to Cord lining, Musculoskeletal regeneration, Multipotent Stem Cell and Dental pulp stem cells.

His most cited work include:

  • Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement (10794 citations)
  • Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement (1467 citations)
  • Granulocyte-Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CML (1334 citations)

What are the main themes of his work throughout his whole career to date?

Armand Keating focuses on Internal medicine, Bone marrow, Transplantation, Surgery and Immunology. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Oncology. As a part of the same scientific study, Armand Keating usually deals with the Bone marrow, concentrating on Stem cell and frequently concerns with Mesenchymal stem cell.

His Mesenchymal stem cell research incorporates themes from Immune system, Cell therapy and Cellular differentiation. His work in Transplantation addresses issues such as Leukemia, which are connected to fields such as Myeloid. The study incorporates disciplines such as Cytotoxic T cell, Molecular biology and Cancer research in addition to Immunology.

He most often published in these fields:

  • Internal medicine (32.25%)
  • Bone marrow (29.70%)
  • Transplantation (27.84%)

What were the highlights of his more recent work (between 2014-2021)?

  • Cancer research (23.43%)
  • Mesenchymal stem cell (23.90%)
  • Internal medicine (32.25%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Cancer research, Mesenchymal stem cell, Internal medicine, Oncology and Stem cell. His Mesenchymal stem cell research is multidisciplinary, incorporating elements of Cell therapy, Stromal cell and Immune system. His study looks at the relationship between Internal medicine and fields such as Surgery, as well as how they intersect with chemical problems.

His Oncology study integrates concerns from other disciplines, such as Diffuse large B-cell lymphoma, Lymphoma and Transplantation. His studies deal with areas such as Wound healing, Toll-like receptor and Neuroscience as well as Stem cell. His Immunology research focuses on subjects like Graft-versus-host disease, which are linked to T cell.

Between 2014 and 2021, his most popular works were:

  • Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells. (79 citations)
  • A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy. (66 citations)
  • TLR3 or TLR4 Activation Enhances Mesenchymal Stromal Cell-Mediated Treg Induction via Notch Signaling. (63 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

His primary areas of study are Mesenchymal stem cell, Cancer research, Stem cell, Immune system and Cell. His Mesenchymal stem cell research is multidisciplinary, incorporating perspectives in Stromal cell and TLR4. His Cancer research research is multidisciplinary, incorporating perspectives in Adipocyte, Microvesicles, Tumor microenvironment, Antibody-dependent cell-mediated cytotoxicity and Antigen.

His Stem cell study combines topics from a wide range of disciplines, such as Toll-like receptor and Pathology. Immune system is a subfield of Immunology that Armand Keating studies. Armand Keating has included themes like Translational medicine, Umbilical cord, Cord, Cytotoxicity and Neuroscience in his Cell study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

M. Dominici;K. Le Blanc;I. Mueller;I. Slaper-Cortenbach.
Cytotherapy (2006)

15656 Citations

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement

E.M. Horwitz;K. Le Blanc;M. Dominici;I. Mueller.
Cytotherapy (2005)

2033 Citations

Granulocyte-Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CML

Catriona H M Jamieson;Laurie E Ailles;Scott J Dylla;Manja Muijtjens.
The New England Journal of Medicine (2004)

1756 Citations

Mesenchymal stromal cells.

Armand Keating.
Current Opinion in Hematology (2006)

779 Citations

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

Corey S. Cutler;Stephanie J. Lee;Peter Greenberg;H. Joachim Deeg.
Blood (2004)

779 Citations

Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.

Shafie Fazel;Massimo Cimini;Liwen Chen;Shuhong Li.
Journal of Clinical Investigation (2006)

602 Citations

Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury

A M Parr;C H Tator;A Keating.
Bone Marrow Transplantation (2007)

596 Citations

Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome

Brian L. McClune;Daniel J. Weisdorf;Tanya L. Pedersen;Gisela Tunes da Silva.
Journal of Clinical Oncology (2010)

546 Citations

Concise review: hitting the right spot with mesenchymal stromal cells.

Jakub Tolar;Katarina Le Blanc;Armand Keating;Bruce R. Blazar.
Stem Cells (2010)

476 Citations

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure

Michel Duval;John P. Klein;Wensheng He;Jean Yves Cahn.
Journal of Clinical Oncology (2010)

377 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Armand Keating

Mohamad Mohty

Mohamad Mohty

Université Paris Cité

Publications: 84

Arnon Nagler

Arnon Nagler

Sheba Medical Center

Publications: 81

Christian Jorgensen

Christian Jorgensen

University of Montpellier

Publications: 74

H. Joachim Deeg

H. Joachim Deeg

Fred Hutchinson Cancer Research Center

Publications: 71

Daniel J. Weisdorf

Daniel J. Weisdorf

University of Minnesota

Publications: 70

Hillard M. Lazarus

Hillard M. Lazarus

Case Western Reserve University

Publications: 68

Sergio Giralt

Sergio Giralt

Memorial Sloan Kettering Cancer Center

Publications: 65

Irving L. Weissman

Irving L. Weissman

Stanford University

Publications: 64

Bipin N. Savani

Bipin N. Savani

Vanderbilt University Medical Center

Publications: 63

Myriam Labopin

Myriam Labopin

Université Paris Cité

Publications: 62

Danièle Noël

Danièle Noël

University of Montpellier

Publications: 58

Darwin J. Prockop

Darwin J. Prockop

Texas A&M University

Publications: 58

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 57

Frederick R. Appelbaum

Frederick R. Appelbaum

Fred Hutchinson Cancer Research Center

Publications: 56

Richard E. Champlin

Richard E. Champlin

The University of Texas MD Anderson Cancer Center

Publications: 55

Stan Gronthos

Stan Gronthos

University of Adelaide

Publications: 53

Something went wrong. Please try again later.